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Abstract 43 
Amyotrophic lateral sclerosis and behavioural variant frontotemporal dementia are two 44 
different diseases recognized to overlap at clinical, pathological and genetic 45 
characteristics. Both conditions are traditionally known for relative sparing of episodic 46 
memory. However, recent studies have disputed that with the report of patients presenting 47 
with marked episodic memory impairment. Besides that, structural and functional 48 
changes in temporal lobe regions responsible for episodic memory processing are often 49 
detected in neuroimaging studies of both conditions. In this study, we investigated the 50 
gray matter features associated with the Papez circuit in amyotrophic lateral sclerosis, 51 
behavioural variant frontotemporal dementia and healthy controls to further explore 52 
similarities and differences between the two conditions. Our non-demented amyotrophic 53 
lateral sclerosis patients showed no episodic memory deficits measured by a short-term 54 
delayed recall test while no changes in gray matter of the Papez circuit were found. 55 
Compared with the amyotrophic lateral sclerosis group, the behavioural variant 56 
frontotemporal dementia group had lower performance on the short-term delayed recall 57 
test and marked atrophy in gray matter of the Papez circuit. Bilateral atrophy of entorhinal 58 
cortex and mammillary bodies distinguished behavioural variant frontotemporal 59 
dementia from amyotrophic lateral sclerosis patients as well as atrophy in left cingulate, 60 
left hippocampus and right parahippocampal gyrus. Taken together, our results suggest 61 
that sub-regions of the Papez circuit could be differently affected in amyotrophic lateral 62 
sclerosis and behavioural variant frontotemporal dementia. 63 
Keywords: amyotrophic lateral sclerosis, behavioural variant frontotemporal dementia, 64 
episodic memory, Papez circuit. 65 
  66 
Introduction 67 
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease 68 
affecting upper and lower motor neurons, eventually leading patients to severe paralysis 69 
and death (for review see Hardiman et al., 2017). In addition to motor symptoms, ALS 70 
patients may display frontotemporal dysfunctions, sometimes leading to a concomitant 71 
diagnose of frontotemporal dementia (FTD), typically compatible with the behavioural 72 
variant FTD (bvFTD; for reviews see Goldstein & Abrahams, 2013; Salameh et al., 2015). 73 
Importantly, subtle psychiatric and cognitive disturbances can precede motor impairment, 74 
causing difficulties to diagnosis ALS before the onset of motor symptoms (for review see 75 
Bak & Hodges, 2001). 76 
bvFTD is also a neurodegenerative disease characterized by progressive 77 
behavioural and cognitive deterioration, with marked structural and functional changes in 78 
frontotemporal regions (for review see Piguet & Hodges, 2011). However, a large 79 
proportion of bvFTD patients can also present with motor disturbances (Lillo & Hodges, 80 
2009).  Clinical, pathological and genetic shared characteristics between ALS and bvFTD 81 
have been recognized (Lillo et al., 2016; Trojsi et al., 2015; Geser et al., 2009; Patel & 82 
Sampson, 2015), but regarding episodic memory, the nature and extent of  deficits remain 83 
unclear in both conditions. 84 
Medial temporal lobe (MTL) structures are associated with episodic memory 85 
processing (for review see Aggleton, 2008) and structural/functional changes in the MTL 86 
are often reported in ALS (Buhour et al, 2017; Christidi et al, 2017;  Kasper et al, 2014; 87 
(Bueno et al., 2018). Despite studies have reported episodic memory deficits in ALS 88 
patients (Trojsi et al, 2016; Kasper et al, 2016; Machts et al., 2014; Consonni et al, 2013; 89 
Consonni et al, 2015), their nature and extent are not clear yet and vary a lot among studies  90 
(Trojsi et al, 2016; Kasper et al, 2016; Machts et al., 2014; Consonni et al, 2013; Consonni 91 
et al, 2015), with encoding and storage/consolidation deficits previously associated with 92 
MTL changes (Christidi et al, 2017; Raaphorst et al, 2015). 93 
In bvFTD, episodic memory is considered relatively spared as per diagnostic 94 
criteria (Rascovsky et al., 2011). However, recent studies have shown encoding 95 
difficulties (Irish et al, 2014; Flanagan et al, 2016), immediate/delayed recall impairments 96 
(Wong et al, 2014; Frisch et al, 2013; Mansoor et al,  2015; Fernández-Matarrubia et al, 97 
2017) and recognition deficits (Fernández-Matarrubia et al, 2017; St. Jacques et al, 2015). 98 
Furthermore, memory findings are in accordance with imaging studies showing 99 
significant MTL changes (Hornberger et al, 2012; Papma et al, 2013; Irish et al, 2014; 100 
Ryan et al, 2017; Wong et al, 2016).   101 
 The Papez circuit originally proposed as responsible for the processing of 102 
emotions (Papez, 1937) is now recognized to be critically involved in mnemonic 103 
processes. Disruptions in any part of the circuit are likely to affect different aspects of 104 
episodic memory depending on the structure affected (for reviews see Aggleton & Brown, 105 
1999; Bubb et al., 2017). Despite its relevance, so far only one study has investigated the 106 
whole Papez network in ALS (Bueno et al., 2018) and another one in bvFTD (Hornberger 107 
et al., 2012). Our previous study showed significant functional changes in the memory 108 
circuit of ALS patients, evidenced by decreased functional connectivity in bilateral 109 
hippocampus, bilateral anterior and posterior parahippocampal gyrus and posterior 110 
cingulate of ALS patients, but preserved episodic memory and minor structural changes 111 
(Bueno et al., 2018). Hornberger and colleagues (2012) reported memory impairment and 112 
significant atrophy in Papez circuit structures in bvFTD. To the best of our knowledge, 113 
no study has compared the morphological characteristics of the Papez circuit between 114 
ALS and bvFTD, conditions that have been suggested to lie on a clinical continuum (for 115 
reviews see Beeldman et al., 2018; Lillo & Hodges, 2009). 116 
To explore potential differences or similarities that could be helpful to 117 
differentiate both diseases when cognitive information is limited and the symptoms 118 
overlap, we employed voxel-based morphometry (VBM) and cortical thickness measures 119 
to investigate degeneration of gray matter (GM) in Papez circuit regions of ALS and 120 
bvFTD patients and healthy controls (HC). These two different magnetic resonance 121 
imaging (MRI) measures can complement each other and therefore are useful tools to 122 
provide higher accuracy for diagnosis and markers of disease progression. We 123 
hypothesised that the Papez circuit could be differently affected in ALS and bvFTD, with 124 
bvFTD showing more atrophy than ALS. 125 
 126 
Materials and methods 127 
Participants 128 
We recruited participants at Hospital das Clínicas of Universidade Federal de 129 
Minas Gerais, in Belo Horizonte, Brazil, following approval by the institution’s human 130 
research ethics committee. All participants and/or their caregivers provided written 131 
consent in accordance with the Declaration of Helsinki and local regulations.  132 
A group of 13 ALS patients was contrasted with 18 bvFTD patients and 13 HC. 133 
ALS patients were diagnosed according to the Awaji criteria (de Carvalho et al., 2008). 134 
None of the ALS patients had a concomitant diagnosis of dementia (ALS-FTD). The 135 
Amyotrophic Lateral Sclerosis Functional Rating Scale - Revised (ALSFRS-R; 136 
Cedarbaum et al., 1999; Guedes et al., 2010) was used to evaluate functional status with 137 
a mean score of 36.36 (range 25-43). Eleven out of the 13 ALS patients were diagnosed 138 
as limb onset. We did not include patients using non-invasive ventilation. bvFTD patients 139 
were classified according to standard diagnostic criteria (Rascovsky et al., 2011). All 140 
bvFTD patients were evaluated by an experienced neurologist for motor neuron disease 141 
and none of them presented signs of motor neuron affection. Controls were recruited from 142 
the community and we did not include participants with previous neurological (e.g. 143 
epilepsy, dementia, multiple sclerosis, etc.) or neurosurgical diseases (e.g., brain tumors), 144 
and we did not include participants with severe psychiatric disorders (e.g., schizophrenia, 145 
bipolar disorder). Moreover, healthy participants had normal scores on the MMSE. None 146 
of the participants had a diagnosis of depression as assessed by the Hospital Anxiety and 147 
Depression scale (HADS; Botega et al., 1995). 148 
 149 
Neuropsychological assessments 150 
All participants underwent cognitive screening with the Mini-Mental State 151 
Examination (MMSE; Brucki et al., 2003). Cognitive assessment was performed with the 152 
Frontal Assessment Battery (FAB; Beato et al., 2007), phonemic fluency test (FAS; 153 
(Machado & Fichman, 2009), animal fluency (Brucki et al., 1997) and digit span 154 
(Zimmermann et al., 2015). Episodic memory was specifically measured by the visual 155 
memory sub-test of the Brief Cognitive Screening Battery (BCSB; Nitrini et al., 1994;  156 
Yassuda et al., 2017). The BCSB is a multidimensional brief test used to discriminate 157 
dementia in populations with heterogeneous educational background and includes the 158 
following categories: memory, visual perception, clock drawing and category fluency 159 
(animals/min.). The memory sub-test consists of the presentation of 10 items followed by 160 
a naming phase, incidental memory, immediate recall, a five-minute delayed recall of the 161 
10 items previously shown and a recognition test.  162 
 163 
MRI acquisition and analyses 164 
 Participants underwent whole-brain MRI on a 3T Philips scan. T1-weighted 165 
images were acquired as follows: multi-shot 256 TFE factor (TR/TE 5.4/2.4ms, 256x256 166 
matrix, FOV 256x256x180, flip angle 8º), slice thickness 1mm, coronal orientation, voxel 167 
size 1x1x1mm3.  168 
We performed VBM analyses using the Statistical Parametric Mapping 12 169 
(SPM12; http://www.fil.ion.ucl.ac.uk/spm). The MRI data were preprocessed following 170 
a standard protocol. First, the anterior commissure of all images was set as the origin of 171 
spatial coordinates. Segmentation algorithm bias-corrected the T1-weighted images for 172 
inhomogeneities and generated rigid-body aligned GM and white matter (WM) of the 173 
subjects. The DARTEL algorithm (Ashburner, 2007) estimated the nonlinear 174 
deformations that best aligned all images together by iteratively registering the imported 175 
images with their average, creating a mean template that was registered to the 176 
International Consortium for Brain Mapping (ICBM) template in the Montreal 177 
Neurological Institute (MNI152) space. The obtained normalized and modulated tissue 178 
probability maps of GM images were smoothed with a 3mm full width at half-maximum 179 
(FWHM) smoothing kernel. Region of interest (ROI) masks were generated using the 180 
WFU PickAtlas (http://www.nitrc.org/projects/wfu_pickatlas). Finally, we extracted the 181 
mean modulated tissue probability map of GM (in-house script in MATLAB) for the 10 182 
ROIs defined as entorhinal cortex: Brodmann areas 28 and 34; parahippocampal gyrus: 183 
Brodmann area 36; cingulate gyrus: Brodmann areas 23. 24, 26, 29, 30, 31, 32 and 33; 184 
hippocampus and mammillary bodies (Lancaster et al., 2000). We used the 185 
Computational Anatomy Toolbox 12 (CAT12; http://www.neuro.uni-jena.de/cat) to 186 
calculate total intracranial volume (TIV).  187 
Cortical thickness and subcortical volumes estimations were obtained with 188 
Freesurfer v6 (http://surfer.nmr.mgh.harvard.edu). Preprocessing pipeline used the fully-189 
automated “recon-all” command and included: normalization, removal of non-brain 190 
tissues, Talairach transforms, segmentation and tessellation of GM and WM boundaries 191 
(Fischl et al., 2004). The cortical surface of each hemisphere was parcellated according 192 
to the atlas proposed by Desikan and colleagues (2006) with 34 cortical regions per 193 
hemisphere; “aparc” segmentation). Cortical thickness was estimated as described 194 
elsewhere (Han et al., 2006; Dale et al., 1999a; Dale et al., 1999b). Subcortical volumes 195 
were obtained via whole-brain automatic “aseg” segmentation procedure (Fischl et al., 196 
2004). Mean cortical thickness was extracted (in-house script in MATLAB) for 16 ROIs 197 
defined as: caudal anterior cingulate, rostral anterior cingulate, isthmus cingulate, 198 
posterior cingulate, entorhinal, parahippocampal, thalamus and hippocampus. 199 
 200 
Statistical analyses 201 
 Kolmogorov–Smirnov and Levene´s tests were used to test normality and 202 
homogeneity of demographic, clinical, neuropsychological and neuroimaging data, 203 
respectively.  Since Kolmogorov-Smirnov and Levene´s tests did not return any 204 
significant result, we verified the differences regarding disease duration and age via one-205 
way analyses of variance (ANOVA) and Tukey´s HSD post hoc tests. Chi-square test was 206 
used to check differences in sex. The processed imaging measures were fit to a general 207 
linear model (GLM) considering ROIs as dependent variables, age (and TIV, for the VBM 208 
data; Barnes et al., 2010) as a covariate, and sex as a fixed factor. Pairwise comparisons 209 
for cognitive scores were obtained using the GLM, considering age as a covariate and sex 210 
as a fixed factor. All tests were two-tailed, and the statistical significance threshold was 211 
set at p<0.05, Bonferroni’s correction where applicable.  212 
 213 
Results 214 
Demographical and clinical characteristics (Table 1) 215 
Chi-square test showed that ALS, bvFTD and HC groups were matched for sex 216 
(χ2 = 1.51, p=0.46). One-way ANOVA indicated ALS and bvFTD demonstrated no 217 
significant differences for disease duration [F(1,29)=0.32, p=0.57]. There was a 218 
statistically significant difference in age between ALS and bvFTD patients (mean 219 
difference = -10.63, p=0.02), with the latter group being older, although neither of the 220 
groups differed from HC. 221 
 222 
Cognitive performance (Table 1) 223 
Comparison with controls: ALS and bvFTD patients showed significant difference in the 224 
MMSE scores compared with HC (mean difference= -2.7, p=0.02; mean difference= -225 
3.1, p=0.004, respectively). In naming, incidental memory and recognition tasks, ALS 226 
and bvFTD groups did not differ from HC. In immediate recall, ALS score was not 227 
statistically significant from HC, but bvFTD showed lower performance compared with 228 
HC (mean difference= -2.09, p=0.001). In delayed recall, the pairwise comparison 229 
showed no significant differences between ALS and HC, but bvFTD showed lower 230 
performance compared with HC, with 7 patients scoring below the cut off score (mean 231 
difference= -2.3, p=0.007). Figure 1 illustrates performances on the delayed recall task.  232 
Patient groups did not differ from HC in FAB or digit span. In animal fluency, no 233 
significant difference was found between ALS and HC, but bvFTD showed lower scores 234 
compared with HC (mean difference= -7.67, p<0.001). In the FAS test, ALS did not differ 235 
from HC, but bvFTD performed worse compared with HC (mean difference= -18.93, 236 
p<0.001). 237 
Comparison between patient groups: No difference was found in the MMSE total scores, 238 
between ALS and bvFTD. Naming, incidental memory and recognition performances of 239 
ALS compared with bvFTD were not statistically different, but there was a difference in 240 
immediate recall, with bvFTD performing worse (mean difference= -1.7, p=0.01). In the 241 
delayed recall task, bvFTD showed significantly worse performance as well (mean 242 
difference= -1.9, p=0.03). ALS and bvFTD showed no statistically significant difference 243 
in FAB and digit span. In animal fluency, there was significant difference between ALS 244 
and bvFTD (mean difference= -6.25, p=0.004), with the latter group presenting lower 245 
scores. In the FAS test, there was a significant difference comparing ALS with bvFTD 246 
(mean difference= -13.08, p=0.02), with bvFTD underperforming ALS. 247 
 248 
[insert Table 1 here]     249 
 [insert Figure 1 here]     250 
 251 
Voxel based morphometry 252 
All VBM results were Bonferroni corrected for multiple comparisons. 253 
Comparison with controls: We did not find significant differences in GM between ALS 254 
and HC in any ROI. When contrasting bvFTD and HC, the former group showed 255 
significantly more atrophy in all Papez circuit structures of both hemispheres (all mean 256 
difference≤ -0.02, all p≤0.05). Supplementary Table 1 shows VBM results.  257 
Comparison between patient groups: bvFTD showed significant more atrophy than ALS 258 
in the left hemisphere for cingulate gyrus (mean difference= -0.04, p=0.02), hippocampus 259 
(mean difference= -0.1, p=0.05), entorhinal cortex (mean difference= -0.06, p=0.02) and 260 
mammillary body (mean difference= -0.03, p=0.04), and in the right hemisphere for 261 
parahippocampal gyrus (mean difference= -0.05, p=0.04), entorhinal cortex (mean 262 
difference= -0.07, p=0.01) and mammillary body (mean difference= -0.04, p=0.03). 263 
Figure 2 and 3 illustrate Papez circuit GM comparison between patient groups. 264 
 265 
     [Insert Figure 2 here] 266
 267 
     [Insert Figure 3 here] 268
 269 
  270 
 271 
Cortical thickness and subcortical volumes 272 
All results were Bonferroni corrected for multiple comparisons. 273 
Comparison with controls: No significant difference in cortical thickness (given in mm) 274 
and subcortical volumes in any ROIs were found comparing ALS with HC. bvFTD 275 
patients showed reduced cortical thickness compared with HC in the left hemisphere for 276 
rostral anterior cingulate (mean difference= -0.32, p=0.01), entorhinal cortex (mean 277 
difference= -0.74, p<0.001), and in the right hemisphere for entorhinal cortex (mean 278 
difference= -0.87, p<0.001) and parahippocampal gyrus (mean difference= -0.41, 279 
p=0.003). Supplementary Table 2 shows cortical thickness measures. 280 
Comparison between patient groups: bvFTD patients showed significant cortical 281 
thickness reduction compared with ALS, in the left hemisphere for rostral anterior 282 
cingulate (mean difference= -0.31, p=0.01), isthmus cingulate (mean difference= -0.24, 283 
p=0.01), entorhinal cortex (mean difference= -0.58, p=0.01) and in right hemisphere for 284 
entorhinal cortex (mean difference= -0.51, p=0.01). Figure 4 and 5 illustrate cortical 285 
thickness differences between patient groups. 286 
 287 
      [Insert Figure 4 here] 288
 289 
      [Insert Figure 5 here] 290
       291 
 Discussion 292 
 293 
This is the first study to compare the classic Papez network between ALS and 294 
bvFTD. Our data revealed no delayed recall impairment in ALS, which was corroborated 295 
by preserved GM of the Papez circuit. At the group level, bvFTD patients performed 296 
slightly above the limits of normality, but a subgroup of patients showed very poor 297 
performance characterizing an amnestic profile. Marked atrophy of the Papez circuit 298 
structures was evidenced in both amnestic and non-amnestic subgroups of bvFTD. We 299 
showed distinct memory profiles in our cohort of ALS and bvFTD supported by different 300 
characteristics of structures composing the Papez circuit. 301 
Memory profile in ALS varies widely among studies from no deficits (Hsieh et 302 
al., 2016) to deficits even in short-term delays (Massman et al., 1996). This large variation 303 
suggests that some ALS patients might present marked EM impairment. Beeldman and 304 
colleagues (2018) showed in their meta-analysis that verbal memory impairment is 305 
consistently found in ALS. However, the identification of patients with memory 306 
impairment may be hampered by the relatively low number of subjects included in the 307 
studies or even the different tests employed. MRI findings also differ and show memory-308 
related structures either preserved or with distinct changes (Bueno ete al. , 2018); Machts 309 
et al., 2018; Buhour et al., 2017; Raaphorst et al., 2015) and this may be related to the 310 
inclusion of patients predominantly in early disease stages. 311 
Likewise, bvFTD patients with marked episodic memory deficits are described in 312 
the literature (Hornberger et al., 2010; Pennington et al., 2011; Bertoux et al., 2014; 313 
Ramanan et al., 2017). Accordingly, MRI studies also show changes in the Papez circuit 314 
or components of this system in bvFTD (Hornberger et al., 2012; de Souza et al., 2013; 315 
Wong et al., 2016). Marked GM atrophy of the Papez circuit is present in bvFTD patients, 316 
but interestingly, our cohort of bvFTD patients had very high performances in the 317 
recognition task and this could suggest that the memory difficulties present could be 318 
related to an executive dysfunction problem instead of a genuine episodic memory deficit. 319 
Although much attention has been traditionally given to hippocampal atrophy, 320 
changes in anterior cingulate are suggested to be a better candidate to distinguish bvFTD 321 
from Alzheimer´s disease (AD; Hornberger et al., 2012). In ALS, studies have also 322 
focused on the hippocampal region (Abdulla et al., 2014; Raaphorst et al., 2015). Here 323 
we show left anterior cingulate and left hippocampal changes in bvFTD while these 324 
regions are spared in ALS. Hornberger and colleagues did not report mammillary bodies 325 
atrophy in their bvFTD cohort despite significant fornix damage. Importantly, marked 326 
bilateral entorhinal and bilateral mammillary bodies atrophy distinguished bvFTD from 327 
ALS in our study.  328 
Our study has important limitations that must be acknowledged. First, the small 329 
sample size in each group limits the generalizability of our findings, hence our analyses 330 
must be replicated in larger cohorts. Importantly, patients in late stages were not included 331 
in the ALS group. This could influence the results as memory problems and brain changes 332 
in the memory circuit could be marked in more advanced stages as suggested by post-333 
mortem neuropathological studies showing TDP-43 depositions in memory related 334 
structures in ALS (e.g., hippocampus; Brettschneider et al., 2013), as well as TDP-43 is 335 
shown to reflect in characteristic damage of WM in bvFTD patients (Kassubek et al., 336 
2018). Additionally, our ALS population consisted on patients who could be classified as 337 
“pure ALS” as they did not show frontal/executive changes to qualify for ALS with 338 
cognitive impairment (Strong et al., 2017) and though this was not purposely done, we 339 
recognize that the inclusion of an ALS group with cognitive changes would enrich the 340 
study.  Another important limitation is that our study is based on clinical diagnosis with 341 
no pathological confirmation. Furthermore, genetic information is not available. It is well 342 
established that ALS patients with  C9orf72 mutations are suggested to be more prone to 343 
cognitive impairment (Strong, 2017), as well as bvFTD patients carrying this mutation 344 
may show different cognitive profiles. Moreover, we acknowledge that not only GM 345 
atrophy influences episodic memory performance, therefore the analyses of other 346 
parameters (e.g., WM of fornix, cingulum bundle among others) should be carried out. 347 
WM analyses have proven to be useful in the study of TDP-43 spread (Gorges et al., 2018 348 
Kassubek et al., 2018);  and therefore, investigations of WM memory related structures 349 
could bring new insights into the study of episodic memory deficits in ALS and bvFTD. 350 
We also suggest more exhaustive cognitive assessment to better characterise the nature 351 
and extension of the memory deficits. And finally, we recognize that educational levels 352 
should be included as an important covariate in studies of the MTL. 353 
Pennington and colleagues (2011) have shown that bvFTD and AD patients can 354 
present similar performances on episodic memory tests, but the deficits have different 355 
neural correlates, with AD presenting prominent temporal lobe atrophy while bvFTD 356 
presents more frontal lobe changes. In our study, bilateral atrophy of entorhinal cortex 357 
and mammillary bodies distinguished bvFTD from ALS patients as well as atrophy in left 358 
cingulate, left hippocampus and right parahippocampal gyrus, however in other studies 359 
these regions are shown to be affected in ALS. Further studies are still warranted to clarify 360 
memory impairments in ALS and if they differ from bvFTD, as well as how the Papez 361 
circuit is affected in both conditions. 362 
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